AMI Asset Management’s GSK GSK Stock Holding History

AMI Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$902K	Buy	17,211 +199	+1%	+$10.5K	0.05%	70
2026 Q1	$939K	Sell	17,012 -96	-0.6%	-$5.2K	0.06%	59
2025 Q4	$839K	Sell	17,108 -586	-3%	-$27.3K	0.05%	66
2025 Q3	$764K	Sell	17,694 -176	-1%	-$6.88K	0.04%	69
2025 Q2	$686K	Sell	17,870 -101	-0.6%	-$3.86K	0.04%	70
2025 Q1	$696K	Sell	17,971 -351	-2%	-$12.8K	0.04%	81
2024 Q4	$620K	Sell	18,322 -496	-3%	-$17.9K	0.03%	83
2024 Q3	$769K	Sell	18,818 -34	-0.2%	-$1.39K	0.04%	75
2024 Q2	$726K	Buy	+18,852	New	+$793K	0.04%	77

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AMI Asset Management's GSK Position: Q2 2026 in Review

AMI Asset Management increased its GSK (GSK) stake by 1.2% in Q2 2026, buying an estimated $10.5K and bringing the position to 17,211 shares worth $902K. The position accounts for 0.05% of the portfolio, ranked #70.

AMI Asset Management first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $939K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

AMI Asset Management held 17,211 shares of GSK worth $902K as of Q2 2026.
AMI Asset Management bought 199 GSK shares in Q2 2026, an estimated $10.5K.
GSK made up 0.05% of AMI Asset Management's portfolio in Q2 2026, its #70 holding.
AMI Asset Management first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
AMI Asset Management's GSK position peaked at $939K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.